Trial Profile
Phase II Trial of Phillips MRI-Guided High Intensity Focused Ultrasound (Sonalleve) and Lyso-thermosensitive Liposomal Doxorubicin (ThermoDox) for Palliation of Painful Bone Metastases
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2022
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer; Bone metastases; Cancer pain; Non-small cell lung cancer; Prostate cancer; Small cell lung cancer
- Focus Therapeutic Use
- Sponsors Imunon
- 19 Sep 2022 According to an Imunon media release, Celsion Corporation changed it's name to Imunon.
- 04 Mar 2016 Status changed from suspended to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 21 Jul 2014 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov record.